Deciphering p53 signaling in tumor suppression

Current Opinion in Cell Biology

Volumn 51, Issue , 2018, Pages 65-72

  Mello, Stephano S ^a   Attardi, Laura D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; CANCER INHIBITION; CANCER STEM CELL; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL INVASION; CELL MOTILITY; CELL PLASTICITY; CELL SPECIFICITY; DNA DAMAGE RESPONSE; EPIGENETICS; GENE EXPRESSION; GENE REPRESSION; GENETIC STABILITY; GENOMIC INSTABILITY; HUMAN; METABOLIC REPROGRAMMING; METABOLISM; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; ANIMAL; DNA DAMAGE; GENETICS; MOUSE;

ANIMALS; APOPTOSIS; DNA DAMAGE; HUMANS; MICE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85037162455     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2017.11.005     Document Type: Review

References (48)

1. Lane, D., Levine, A., p53 research: the past thirty years and the next thirty years. Cold Spring Harb Perspect Biol, 2, 2010 a000893.
2. Garcia, P.B., Attardi, L.D., Illuminating p53 function in cancer with genetically engineered mouse models. Semin Cell Dev Biol 27 (2014), 74–85.
3. Bieging, K.T., Mello, S.S., Attardi, L.D., Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14 (2014), 359–370.
4. Hinkal, G., Parikh, N., Donehower, L.A., Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression. PLoS ONE, 4, 2009, e6654.
5. Efeyan, A., Garcia-Cao, I., Herranz, D., Velasco-Miguel, S., Serrano, M., Tumour biology: policing of oncogene activity by p53. Nature, 443, 2006 159-159.
6. Christophorou, M.A., Ringshausen, I., Finch, A.J., Swigart, L.B., Evan, G.I., The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443 (2006), 214–217.
7. Brady, C.A., Jiang, D., Mello, S.S., Johnson, T.M., Jarvis, L.A., Kozak, M.M., Broz, D.K., Basak, S., Park, E.J., McLaughlin, M.E., et al. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell 145 (2011), 571–583.
8. Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., Baer, R., Gu, W., Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149 (2012), 1269–1283.
9. Valente Liz, J., Gray Daniel, H.D., Michalak Ewa, M., Pinon-Hofbauer, J., Egle, A., Scott Clare, L., Janic, A., Strasser, A., p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. Cell Rep 3 (2013), 1339–1345.
10. Hemann, M.T., Zilfou, J.T., Zhao, Z., Burgess, D.J., Hannon, G.J., Lowe, S.W., Suppression of tumorigenesis by the p53 target PUMA. Proc Natl Acad Sci U S A 101 (2004), 9333–9338.
11. Valente, L.J., Grabow, S., Vandenberg, C.J., Strasser, A., Janic, A., Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53. Oncogene 35 (2016), 3866–3871.
12. Sengupta, S., Harris, C.C., p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6 (2005), 44–55.
13. Ganem Neil, J., Cornils, H., Chiu, S.-Y., O'Rourke Kevin, P., Arnaud, J., Yimlamai, D., Théry, M., Camargo Fernando, D., Pellman, D., Cytokinesis failure triggers hippo tumor suppressor pathway activation. Cell 158 (2014), 833–848.
14. Klusmann, I., Rodewald, S., Müller, L., Friedrich, M., Wienken, M., Li, Y., Schulz-Heddergott, R., Dobbelstein, M., p53 activity results in DNA replication fork processivity. Cell Rep 17 (2016), 1845–1857 This paper reports that p53 activation can enhance replication fork progression, a mechanism through which p53 can promote genomic stability.
15. Yeo, C.Q., Alexander, I., Lin, Z., Lim, S., Aning, O.A., Kumar, R., Sangthongpitag, K., Pendharkar, V., Ho, V.H., Cheok, C.F., p53 maintains genomic stability by preventing interference between transcription and replication. Cell Rep 15 (2016), 132–146 This paper describes a new function of p53 — the coordination between transcription and replication — which is important for promoting normal replication fork progression.
16. Wylie, A., Jones, A.E., D'Brot, A., Lu, W.-J., Kurtz, P., Moran, J.V., Rakheja, D., Chen, K.S., Hammer, R.E., Comerford, S.A., et al. p53 genes function to restrain mobile elements. Genes Dev 30 (2015), 64–77 Using Drosophila, zebrafish, and human cancer cells, Wylie et al. show that p53 can restrict retrotransposon activity, thereby preserving genome integrity and suggesting a mechanism for tumor suppression.
17. Levine, A.J., Ting, D.T., Greenbaum, B.D., P53 and the defenses against genome instability caused by transposons and repetitive elements. Bioessays 38 (2016), 508–513.
18. Dudgeon, C., Chan, C., Kang, W., Sun, Y., Emerson, R., Robins, H., Levine, A.J., The evolution of thymic lymphomas in p53 knockout mice. Genes Dev 28 (2014), 2613–2620.
19. Tovy, A., Spiro, A., McCarthy, R., Shipony, Z., Aylon, Y., Alton, K., Ainbinder, E., Furth, N., Tanay, A., Barton, M., et al. p53 is essential for DNA methylation homeostasis in naïve embryonic stem cells, and its loss promotes clonal heterogeneity. Genes Dev 31 (2017), 959–972.
20. Park, I.Y., Sohn, B.H., Choo, J.H., Joe, C.O., Seong, J.K., Lee, Y.I., Chung, J.H., Deregulation of DNA methyltransferases and loss of parental methylation at the insulin-like growth factor II (Igf2)/H19 loci in p53 knockout mice prior to tumor development. J Cell Biochem 94 (2005), 585–596.
21. Ward Patrick, S., Thompson Craig, B., Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21 (2012), 297–308.
22. Kruiswijk, F., Labuschagne, C.F., Vousden, K.H., p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol 16 (2015), 393–405.
23. Kenzelmann Broz, D., Mello, S.S., Bieging, K.T., Jiang, D., Dusek, R.L., Brady, C.A., Sidow, A., Attardi, L.D., Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes Dev 27 (2013), 1016–1031.
24. Olivos, D.J., Mayo, L.D., Emerging non-canonical functions and regulation by p53: p53 and stemness. Int J Mol Sci, 2016, 17.
25. McConnell, A.M., Yao, C., Yeckes, A.R., Wang, Y., Selvaggio, A.S., Tang, J., Kirsch, D.G., Stripp, B.R., p53 regulates progenitor cell quiescence and differentiation in the airway. Cell Rep 17 (2016), 2173–2182.
26. Mizuno, H., Spike, B.T., Wahl, G.M., Levine, A.J., Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Proc Natl Acad Sci U S A 107 (2010), 22745–22750.
27. Krizhanovsky, V., Lowe, S.W., Stem cells: the promises and perils of p53. Nature 460 (2009), 1085–1086.
28. Merkle, F.T., Ghosh, S., Kamitaki, N., Mitchell, J., Avior, Y., Mello, C., Kashin, S., Mekhoubad, S., Ilic, D., Charlton, M., et al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature, 2017 advance online publication.
29. Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., Yamanaka, S., Suppression of induced pluripotent stem cell generation by the p53–p21 pathway. Nature 460 (2009), 1132–1135.
30. Choi, Y.J., Lin, C.-P., Ho, J.J., He, X., Okada, N., Bu, P., Zhong, Y., Kim, S.Y., Bennett, M.J., Chen, C., et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 13 (2011), 1353–1360.
31. Nakagawa, S., Hirose, T., Paraspeckle nuclear bodies — useful uselessness?. Cell Mol Life Sci 69 (2012), 3027–3036.
32. Mello, S.S., Sinow, C., Raj, N., Mazur, P.K., Bieging-Rolett, K., Broz, D.K., Imam, J.F.C., Vogel, H., Wood, L.D., Sage, J., et al. Neat1 is a p53-inducible lincRNA essential for transformation suppression. Genes Dev 31 (2017), 1095–1108 In this paper the authors identify Neat1 as a p53-induced lincRNA and demonstrate that Neat1 deficiency enhances transformation. Neat1 function is associated with its ability to preserve differentiation in oncogene-expressing cells.
33. Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., Gu, W., Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520 (2015), 57–62 This article shows that p53 can induce ferroptosis, an alternative cell death mechanism that could contribute to tumor suppression.
34. Wang, S.J., Li, D., Ou, Y., Jiang, L., Chen, Y., Zhao, Y., Gu, W., Acetylation is crucial for p53-mediated ferroptosis and tumor suppression. Cell Rep 17 (2016), 366–373.
35. Jennis, M., Kung, C.P., Basu, S., Budina-Kolomets, A., Leu, J.I., Khaku, S., Scott, J.P., Cai, K.Q., Campbell, M.R., Porter, D.K., et al. An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model. Genes Dev 30 (2016), 918–930.
36. Xie, Y., Zhu, S., Song, X., Sun, X., Fan, Y., Liu, J., Zhong, M., Yuan, H., Zhang, L., Billiar, T.R., et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep 20 (2017), 1692–1704.
37. Muller, P.A.J., Vousden, K.H., Norman, J.C., p53 and its mutants in tumor cell migration and invasion. J Cell Biol 192 (2011), 209–218.
38. Chang, C.-J., Chao, C.-H., Xia, W., Yang, J.-Y., Xiong, Y., Li, C.-W., Yu, W.-H., Rehman, S.K., Hsu, J.L., Lee, H.-H., et al. p53 regulates epithelial–mesenchymal transition (EMT) and stem cell properties through modulating miRNAs. Nat Cell Biol 13 (2011), 317–323.
39. Kim, N.H., Kim, H.S., Li, X.Y., Lee, I., Choi, H.S., Kang, S.E., Cha, S.Y., Ryu, J.K., Yoon, D., Fearon, E.R., et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition. J Cell Biol 195 (2011), 417–433.
40. Caswell, D.R., Chuang, C.-H., Yang, D., Chiou, S.-H., Cheemalavagu, S., Kim-Kiselak, C., Connolly, A., Winslow, M.M., Obligate progression precedes lung adenocarcinoma dissemination. Cancer Disc 4 (2014), 781–789.
41. Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D.F., Bolden, J.E., Zhao, Z., Thapar, V., Joyce, J.A., Krizhanovsky, V., et al. Non-cell-autonomous tumor suppression by p53. Cell 153 (2013), 449–460.
42. Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., Lowe, S.W., Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007), 656–660.
43. Bergers, G., Benjamin, L.E., Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3 (2003), 401–410.
44. Sachdeva, M., Zhu, S., Wu, F., Wu, H., Walia, V., Kumar, S., Elble, R., Watabe, K., Mo, Y.-Y., p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci 106 (2009), 3207–3212.
45. Mello, S.S., Valente, L.J., Raj, N., Seoane, J.A., Flowers, B.M., McClendon, J., Bieging-Rolett, K.T., Lee, J., Ivanochko, D., Kozak, M.M., et al. A p53 super-tumor suppressor reveals a tumor suppressive p53–Ptpn14–Yap axis in pancreatic cancer. Cancer Cell 32 (2017), 460–473 This study uncovers a p53–Ptpn14–Yap axis that is integral to p53-mediated tumor suppression, connecting p53 to the Hippo pathway and providing support for the idea that Yap activation in tumors is associated with p53 loss.
46. Halazonetis, T.D., Gorgoulis, V.G., Bartek, J., An oncogene-induced DNA damage model for cancer development. Science 319 (2008), 1352–1355.
47. Bieging-Rolett, K.T., Johnson, T.M., Brady, C.A., Beaudry, V.G., Pathak, N., Han, S., Attardi, L.D., p19(Arf) is required for the cellular response to chronic DNA damage. Oncogene 35 (2016), 4414–4421.
48. Hammond, E.M., Giaccia, A.J., The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 331 (2005), 718–725.